HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erwin A van Vliet Selected Research

Brain Diseases (Brain Disorder)

12/2017Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs.
2/2014Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erwin A van Vliet Research Topics

Disease

35Epilepsy (Aura)
02/2023 - 07/2002
29Seizures (Absence Seizure)
01/2022 - 08/2002
26Status Epilepticus (Complex Partial Status Epilepticus)
01/2022 - 08/2002
23Temporal Lobe Epilepsy
01/2022 - 07/2002
13Inflammation (Inflammations)
08/2022 - 07/2011
8Tuberous Sclerosis (Bourneville's Disease)
01/2022 - 01/2018
4Focal Cortical Dysplasia
10/2021 - 01/2019
4Neuroinflammatory Diseases
11/2020 - 03/2014
4Encephalitis (Encephalitis, Rasmussen)
01/2019 - 07/2011
3Gliosis
08/2022 - 01/2016
3Inborn Genetic Diseases (Disease, Hereditary)
01/2022 - 01/2020
3Hippocampal Sclerosis
10/2021 - 09/2011
3Epileptic Syndromes
01/2021 - 07/2002
3Breast Neoplasms (Breast Cancer)
01/2020 - 06/2005
3Neoplasms (Cancer)
12/2012 - 09/2003
2Brain Injuries (Brain Injury)
02/2023 - 01/2021
2Drug Resistant Epilepsy
01/2022 - 09/2003
2Carcinogenesis
01/2020 - 06/2018
2Astrocytoma (Pilocytic Astrocytoma)
01/2020 - 06/2018
2Disease Progression
01/2019 - 07/2017
2Ganglioglioma
06/2018 - 09/2003
2Glioma (Gliomas)
06/2018 - 12/2012
2Glioblastoma (Glioblastoma Multiforme)
06/2018 - 12/2012
2Brain Diseases (Brain Disorder)
12/2017 - 02/2014
2Central Nervous System Diseases (CNS Diseases)
05/2014 - 09/2009
1Post-Traumatic Epilepsy (Epilepsy, Post Traumatic)
02/2023
1Traumatic Brain Injuries (Traumatic Brain Injury)
02/2023
1Nervous System Diseases (Neurological Disorders)
08/2022
1Autism Spectrum Disorder
01/2022
1Intellectual Disability (Idiocy)
01/2022
1Neurodevelopmental Disorders
10/2021
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1Cognitive Dysfunction
01/2021
1Sudden Unexpected Death in Epilepsy
01/2021
1Malformations of Cortical Development
01/2020
1Hamartoma
01/2020
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Hemimegalencephaly
01/2019
1Myoclonic Epilepsies (Myoclonic Encephalopathy)
11/2018
1Body Weight (Weight, Body)
01/2016

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
7Kainic Acid (Kainate)IBA
01/2021 - 06/2003
6MicroRNAs (MicroRNA)IBA
02/2023 - 02/2014
6Biomarkers (Surrogate Marker)IBA
02/2023 - 04/2013
6trans-sodium crocetinate (crocetin)IBA
01/2022 - 01/2019
6TOR Serine-Threonine KinasesIBA
10/2021 - 07/2012
6Sirolimus (Rapamycin)FDA Link
01/2019 - 07/2012
5Messenger RNA (mRNA)IBA
01/2021 - 06/2003
5Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2020 - 07/2008
4Matrix Metalloproteinases (MMPs)IBA
08/2022 - 07/2018
3RNA (Ribonucleic Acid)IBA
02/2023 - 10/2006
3Matrix Metalloproteinase InhibitorsIBA
08/2022 - 07/2018
3CurcuminIBA
01/2022 - 01/2016
3AntioxidantsIBA
01/2022 - 01/2019
3IronIBA
10/2021 - 09/2005
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2021 - 02/2010
3CytokinesIBA
07/2018 - 12/2012
3Sodium Channels (Sodium Channel)IBA
09/2013 - 07/2002
3Levetiracetam (Keppra)FDA LinkGeneric
03/2010 - 07/2008
3Phenytoin (Dilantin)FDA LinkGeneric
02/2010 - 04/2006
2Indicators and Reagents (Reagents)IBA
01/2022 - 09/2005
2Adenosine Triphosphate (ATP)IBA
01/2020 - 06/2005
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020 - 06/2005
2Drug CombinationsIBA
01/2019 - 07/2017
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 04/2013
2Glycine (Aminoacetic Acid)FDA LinkGeneric
12/2015 - 05/2014
2InterleukinsIBA
10/2015 - 04/2013
2Phenobarbital (Luminal)FDA Link
05/2014 - 06/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2010 - 02/2010
2major vault proteinIBA
12/2004 - 09/2003
1salicylhydroxamic acid (SHAM)IBA
02/2023
1Cell Adhesion MoleculesIBA
01/2022
1Mechanistic Target of Rapamycin Complex 1IBA
10/2021
1Metalloproteases (Metalloproteinases)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1ProteomeIBA
01/2021
1AlbuminsIBA
11/2020
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2020
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2019
1Ion Channels (Ion Channel)IBA
01/2019
1Aminobutyrates (Aminobutyric Acid)IBA
11/2018
1docosapentaenoic acidIBA
11/2018
1BenzodiazepinesIBA
11/2018
1CannabidiolIBA
11/2018
1ChloridesIBA
11/2018
1protectin D1IBA
11/2018
1Flunitrazepam (Rohypnol)IBA
11/2018
1gamma-Aminobutyric Acid (GABA)IBA
11/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
01/2018
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017
1Therapeutic UsesIBA
01/2016
1gadobutrolIBA
01/2016
1Contrast MediaIBA
01/2016
1LY2365109IBA
12/2015
1Glycine Plasma Membrane Transport ProteinsIBA
12/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2015
1Phosphotransferases (Kinase)IBA
10/2015

Therapy/Procedure

9Therapeutics
10/2021 - 02/2014
1Craniotomy
02/2023
1Aftercare (After-Treatment)
11/2018